U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: June 25 - July 1, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: June 25 - July 1, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 06/26/2023
Location: Virtual
Subject: Supply Chain Resiliency
FDA Participant/Group: N/A
Non FDA Participant/Group: Albert Bourla (Pfizer);

Event Date: 06/26/2023
Location: Virtual
Subject: Oxford Population Health: 10th Anniversary Symposium - Conditions are Right for Transition to a Learning Health System
FDA Participant/Group: BETH FRITSCH;
Non FDA Participant/Group: Several members of academia

Event Date: 06/27/2023
Location: Virtual
Subject: Update on FDA Human Foods Program
FDA Participant/Group: LAURA CARROLL;
Non FDA Participant/Group: Peter Lurie (Center for Science in the Public Interest);

Event Date: 06/27/2023
Location: Virtual
Subject: Update on FDA Human Foods Program
FDA Participant/Group: LAURA CARROLL; JULIA TIERNEY;
Non FDA Participant/Group: Scott Gottlieb (New Enterprise Associates); Mark McClellan (Duke University); Andrew Von Eschenbach (Samaritan Health); Jane Henney (University of Cincinnati Academic Health Center); Steven Hahn (Flagship Pioneering); David Kessler (University of California, San Francisco);

Event Date: 06/27/2023
Location: Virtual
Subject: Update on FDA Human Foods Program
FDA Participant/Group: LAURA CARROLL;
Non FDA Participant/Group: Ted McKinney (National Association of State Departments of Agriculture); Doug Miyamoto (Wyoming Department of Health);

Event Date: 06/27/2023
Location: Virtual
Subject: Update on FDA Human Foods Program
FDA Participant/Group: LAURA CARROLL;
Non FDA Participant/Group: Scott Faber (Environmental Working Group);

Event Date: 06/27/2023
Location: Washington, DC
Subject: AdvaMed Second Quarter Board Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of AdvaMed board and staff

Event Date: 06/27/2023
Location: Virtual
Subject: Update on FDA Human Foods Program
FDA Participant/Group: LAURA CARROLL;
Non FDA Participant/Group: David Chavern (Consumer Brands Association);

Event Date: 06/28/2023
Location: Virtual
Subject: National Institute of Deafness and Other Communications Disorders Director's Seminar Series: Advancing the Science of Communication to Improve Lives
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other registered attendees

Event Date: 06/28/2023
Location: Virtual
Subject: Update on Proposal to Unify FDA Human Foods Program
FDA Participant/Group: Several FDA Staff participated
Non FDA Participant/Group: Several stakeholder groups interested in the FDA Human Foods Program

Event Date: 06/28/2023
Location: Virtual
Subject: Update on FDA Human Foods Program
FDA Participant/Group: LAURA CARROLL;
Non FDA Participant/Group: Steve Mandernach (Association of Food and Drug Officials);

Event Date: 06/30/2023
Location: Naknek, AK
Subject: Federal Fisheries Roundtable
FDA Participant/Group: KIMBERLEE TRZECIAK;
Non FDA Participant/Group: Government and industry

Event Date: 06/30/2023
Location: Naknek, AK
Subject: Trident Seafood Tour
FDA Participant/Group: KIMBERLEE TRZECIAK;
Non FDA Participant/Group: Government and industry

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 06/30/2023
Location: Virtual
Subject: Good Clinical Trials Collaborative Steering Group Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Good Clinical Collaborative Steering Group members

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 06/29/2023
Location: Boston, MA
Subject: Drug Information Association (DIA) 2023 Global Annual Meeting; European Medicines Agency (EMA) - FDA Question Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, regulatory, and other stakeholders

Event Date: 06/29/2023
Location: Boston, MA
Subject: Drug Information Association (DIA) 2023 Global Annual Meeting; Bilateral Meeting with Taiwan FDA
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from Taiwan FDA

Event Date: 06/29/2023
Location: Boston, MA
Subject: Drug Information Association (DIA) 2023 Global Annual Meeting; FDA Town Hall
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, regulatory, and other stakeholders

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Carol Cave, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 06/26/2023
Location: Virtual
Subject: Drug Information Association (DIA) 2023 Global Annual Meeting; Speaker: Combating Misinformation with Authoritative Medical Product Information
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, regulatory, and other stakeholders

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/26/2023
Location: Virtual
Subject: 2023 International Society for Pharmaceutical Engineering Biotechnology Conference: The Importance of Manufacturing in the Development of Advanced Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and regulatory stakeholders

Event Date: 06/26/2023
Location: Boston, MA
Subject: Drug Information Association; Panelist: Accelerated Approval in Rare Disease: The Role of Novel Biomarker, Surrogate Endpoints, and Other Innovative Approaches in Expediting Development
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, regulatory, academia, and patient stakeholders

Event Date: 06/26/2023
Location: Boston, MA
Subject: Drug Information Association; Panelist: The Promise of Vaccine Platforms to Advance Regulatory Science: Where are We Now, Where are We Going, and How do We Get There?
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, regulatory, academia, and patient stakeholders

Event Date: 06/27/2023
Location: Washington, DC
Subject: National Institute for Innovation in Manufacturing Biopharmaceuticals; Speaker: The Role of Manufacturing in Realizing the Promise of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and federal stakeholders

Event Date: 06/27/2023
Location: Virtual
Subject: Vaccine Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Association of State and Territorial Health Officials

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 06/29/2023
Location: Virtual
Subject: Implementation of the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act of 2021
FDA Participant/Group: KARI BARRETT; EMILY ROSE CAREY; JENNIFER DOOREN; PATRICIA HANSEN; STEFANO LUCCIOLI; YINQING MA;
Non FDA Participant/Group: Charmayne Anderson (Allergy and Asthma Network (AAN)); Sarah Sorscher (Center for Science in the Public Interest (CSPI)); Ellyn Kodroff (Campaign Urging Research for Eosinophilic Disease (CURED)); Thomas Silvera (Elijah-Alavi Foundation); Kenneth Mendez (Asthma and Allergy Foundation of America (AAFA)); Erin Malawer (AllergyStrong); Chris Olsen (Food Allergy Science Initiative (FASI)); Bob Earl, Jason Linde (Food Allergy Research and Education (FARE)); Caroline Moassessi (Food Allergy and Anaphylaxis Connection Team (FAACT));

Event Date: 06/29/2023
Location: Harrisburg, PA
Subject: United Natural Foods, Inc. (UNFI) Distribution Center Tour
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Jeff Cowan (GS1 U.S.); Kelly Kline (Pennsylvania Department of Agriculture); Adriana Alfaro, Hilary Thesmer, Jennifer Hatcher, Leslie Sarasin, Stephanie Harris (Food Marketing Institute (FMI)); Josh George, Letta Jenkins (United Natural Foods, Inc. (UNFI));

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 06/28/2023
Location: Virtual
Subject: Juul Labs Inc Listening Session; State Settlement Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from Juul Labs, Inc

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

Event Date: 06/26/2023
Location: Washington, DC
Subject: Advamed Legal Committee
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Uta Rawsons (Advamed);

 

 
Back to Top